Breast cancer represents a leading cause of death worldwide. Despite the advances in
systemic therapies, the prognosis for patients with breast cancer liver metastasis (BCLM) …

Background The liver is involved in about half of patients with metastatic breast cancer.
Unfortunately systemic chemotherapy as the treatment of choice is limited. Due to …

Aim To analyze surgical treatment of breast cancer liver metastases (BCLM) regarding
selection criteria, outcome and prognostic parameters. Methods We searched Embase and …

Purpose To retrospectively assess the local control and intermediate-and long-term survival
of patients with liver metastases from breast cancer who have undergone percutaneous …

Objective: To evaluate the comparative therapeutic efficacy of radiofrequency ablation (RFA)
and hepatic resection (HR) for breast cancer liver metastases (BCLMs). Methods: Studies …

Objective: To evaluate the long-term efficacy and prognostic factors of ultrasound-guided
percutaneous radiofrequency ablation (RFA) for breast cancer liver metastasis (BCLM) …

Objective: To evaluate the efficacy of surgical treatment for patients with isolated breast
cancer liver metastases (BCLM). Background: Single-arm retrospective studies have shown …

Liver metastases from breast cancer (LMBC) have long been considered as a systemic
disease because of the hematological route of dissemination, requiring noncurative …

PURPOSE: To evaluate the results of radiofrequency ablation in treating hepatic metastases
from breast cancer. MATERIALS AND METHODS: Fourteen breast cancer patients with 16 …

Background Data on surgical management of breast liver metastasis are limited. We sought
to determine the safety and long-term outcome of patients undergoing hepatic resection of …